XSPRAY — XSpray Pharma AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.30bn
- SEK1.22bn
Annual cashflow statement for XSpray Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -53.5 | -98 | -133 | -182 | -287 |
| Depreciation | |||||
| Non-Cash Items | -0.113 | 31.2 | 15.5 | 0.046 | 52.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.91 | 6.25 | -2.11 | -30.8 | 3.92 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -47.8 | -51.6 | -110 | -203 | -222 |
| Capital Expenditures | -93.6 | -96 | -128 | -54.1 | -42.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.27 | -9.85 | -7.06 | -11.8 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -96.8 | -106 | -135 | -65.9 | -42.1 |
| Financing Cash Flow Items | 11.7 | 4.34 | -4.88 | -26.2 | -21.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 260 | 104 | 93.8 | 316 | 306 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 116 | -53.7 | -152 | 46.1 | 41.9 |